Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2000331	冻干静注人免疫球蛋白（pH4）	Human Immunoglobulin(pH4)	Lyophilized	Biological Products	Supplementary Application	2020-12-09	国药集团上海血液制品有限公司	Sinopharm Shanghai Plasma-derived Biotherapies Co Ltd	In Review	2020-12-08	view
CYSB2000330	冻干静注人免疫球蛋白（pH4）	Human Immunoglobulin(pH4)	Lyophilized	Biological Products	Supplementary Application	2020-12-09	国药集团上海血液制品有限公司	Sinopharm Shanghai Plasma-derived Biotherapies Co Ltd	In Review	2020-12-08	view
CYSB2000334	人纤维蛋白原	Human fibrinogen	Lyophilized	Biological Products	Supplementary Application	2020-12-09	国药集团上海血液制品有限公司	Sinopharm Shanghai Plasma-derived Biotherapies Co Ltd	In Review	2020-12-08	view
CYSB2000329	静注人免疫球蛋白（pH4）	Human Immunoglobulin(pH4)	Injection	Biological Products	Supplementary Application	2020-12-07	国药集团上海血液制品有限公司	Sinopharm Shanghai Plasma-derived Biotherapies Co Ltd	In Review	2020-12-07	view
CYSB2000328	静注人免疫球蛋白（pH4）	Human Immunoglobulin(pH4)	Injection	Biological Products	Supplementary Application	2020-12-07	国药集团上海血液制品有限公司	Sinopharm Shanghai Plasma-derived Biotherapies Co Ltd	In Review	2020-12-07	view
CYSB1800188	人凝血酶原复合物	human prothrombin complex	Lyophilized	Biological Products	Supplementary Application	2018-09-17	国药集团上海血液制品有限公司	Sinopharm Shanghai Plasma-derived Biotherapies Co Ltd	Certificate Issued	2019-08-20	view